Latest News in the pharma Industry

All

Extractables-free deep-well plate for uHPLC and MS applications

Extractables-free deep-well plate for uHPLC and MS applications

2 Jun 2017

Porvair Glass Vial Deep-well plates are precisely manufactured to ensure complete compatibility with automated equipment.

Read more 
NICE approves first use of Opdivo in blood cancer

NICE approves first use of Opdivo in blood cancer

2 Jun 2017

NICE has recommended immunotherapy drug nivolumab for the treatment of adult patients with classical Hodgkin lymphoma.

Read more 
Vertex reaches long-term reimbursement agreement with ROI for Orkambi, Kalydeco and future CF medicines

Vertex reaches long-term reimbursement agreement with ROI for Orkambi, Kalydeco and future CF medicines

1 Jun 2017

Agreement provides access to Orkambi for people who have two copies of the F508del mutation and expands access to Kalydeco for all eligible patients.

Read more 
NIH researchers find potential genetic cause of Cushing syndrome

NIH researchers find potential genetic cause of Cushing syndrome

1 Jun 2017

Finding may lead to therapies that prevent pituitary tumor recurrence.

Read more 
Cardinal Health Specialty Solutions publishes research-based insights on oncology

Cardinal Health Specialty Solutions publishes research-based insights on oncology

1 Jun 2017

Pharmaceutical companies should play a larger role in patient support programs.

Read more 
Hikma signs an exclusive license and supply agreement with Octapharma for Octaplex

Hikma signs an exclusive license and supply agreement with Octapharma for Octaplex

1 Jun 2017

Deal adds the first plasma-derived treatment to Hima's product offering.

Read more 
Sandoz proposed biosimilars adalimumab and infliximab accepted for regulatory review by the EMA

Sandoz proposed biosimilars adalimumab and infliximab accepted for regulatory review by the EMA

31 May 2017

Biosimilar infliximab alone could potentially save the NHS £89 million.

Read more 
Vetter and Microdermics to develop innovative microneedle drug delivery systems

Vetter and Microdermics to develop innovative microneedle drug delivery systems

31 May 2017

Microdermics has successfully demonstrated the initial safety of its microneedle system, and is planning Phase I human clinical trials for vaccine and therapeutic delivery, to be initiated in 2017.

Read more 
Synimmune initiates FiH study of Fc-optimized antibody Flysyn for the treatment of AML

Synimmune initiates FiH study of Fc-optimized antibody Flysyn for the treatment of AML

31 May 2017

Flysyn is the first antibody from the company's pipeline to be tested in humans.

Read more 
Cambrex invests in new capacity and continuous flow technology at its Karlskoga, Sweden facility

Cambrex invests in new capacity and continuous flow technology at its Karlskoga, Sweden facility

30 May 2017

The expansion is part of an ongoing strategic campaign to invest in small molecule API manufacturing across the company's global network of facilities.

Read more 
Sanner acquisition strengthens company's leadership in effervescent packaging market

Sanner acquisition strengthens company's leadership in effervescent packaging market

30 May 2017

Acquisition of Jaco enables Sanner to operate as a system supplier.

Read more 
Orchard Therapeutics signs manufacturing services agreement with PCT Cell Therapy Services

Orchard Therapeutics signs manufacturing services agreement with PCT Cell Therapy Services

30 May 2017

Under the terms of this new agreement, PCT will provide GMP-compliant manufacturing services for Orchard’s lead product, OTL-101, an autologous ex-vivo gene therapy for the treatment of ADA-SCID.

Read more